Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_assertion type Assertion NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_head.
- NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_assertion description "[Taken together, these results indicate that 2-DG enhances TRAIL-induced apoptosis in breast cancer cells by multiple mechanisms including suppression of RIP1, and highlight the potential therapeutic benefit of combinations of 2-DG and TRAIL in the treatment of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_provenance.
- NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_assertion evidence source_evidence_literature NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_provenance.
- NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_assertion SIO_000772 23499682 NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_provenance.
- NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_assertion wasDerivedFrom befree-20140225 NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_provenance.
- NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_assertion wasGeneratedBy ECO_0000203 NP259204.RAEygfoaTXa5O9edLLGd7WU7_DGpvO5GiQktK1psd_e6c130_provenance.